New Milton, Hampshire, UK, 26 March 2009 – Genetix Ltd, the leading provider of solutions for imaging and intelligent image analysis, has re-launched its website (www.genetix.com) in line with the Company’s new focus areas. Genetix’ systems are used by scientists and clinicians in mainstream research, in the development of pharmaceuticals and biotherapeutics, and in clinical diagnostics.

The Company has consistently developed innovative solutions that reflect changing application requirements in the life science market. For example, Genetix QPix systems set the industry standard for imaging and selection of microbial colonies, while the ClonePix™ FL system is acknowledged as the leading solution for screening and selection of secretory mammalian colonies. CloneSelect™ Imager, for quantitative assessment of cell growth, and CellReporter™, a system to quantify cellular responses, provide additional tools based on imaging and analysis. Leveraging its expertise in imaging at the cellular level, the company has also successfully introduced Ariol®, a platform solution for quantification of tissue biomarkers.

In the diagnostic sector, Genetix’ CytoVision® is the platform of choice for chromosomal investigations and is widely used in cytogenetics laboratories in more than 80 countries worldwide.

Major benefits of the re-designed site include an enhanced structure and functionality, enabling easy access to information on Genetix’ complete range of innovative systems, application notes, scientific posters and protocol booklets. For added convenience registered visitors can also place orders for reagents, supplies, spare parts and accessories via the online system.

About Genetix

Headquartered in New Milton, UK, with offices in the UK, US, Germany and Japan, and quoted on the AIM (GTX: AIM), Genetix provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis in the life science and diagnostic markets.

In research, pharmaceutical and biotherapeutic development, the Company’s systems set industry standards for accurate selection of microbial colonies, and for screening and selection of mammalian secretory cell lines. Other systems evaluate the response of cells to potential therapeutic agents and quantify tissue biomarkers.

In diagnostics, Genetix holds a leading position in genetic testing with thousands of the Company’s platforms used in laboratories worldwide.

Through its expertise in robotics, cell and molecular biology, image analysis and interpretation, supported by a strong IP portfolio, Genetix is committed to the continual development of innovative solutions.